N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD

NCT00539188 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to poor subject compliance.

Conditions

Borderline Personality Disorder
Self-Injurious Behavior

Interventions

DRUG: N-Acetylcysteine
DRUG: placebo

Sponsor

Yale University